دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش:
نویسندگان: Dafang Wu
سری:
ISBN (شابک) : 3030408922, 9783030408923
ناشر: Springer
سال نشر: 2020
تعداد صفحات: 394
زبان: English
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود)
حجم فایل: 36 مگابایت
در صورت تبدیل فایل کتاب Clinical Nuclear Medicine Neuroimaging: An Instructional Casebook به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب تصویربرداری عصبی پزشکی هسته ای بالینی: کتاب موردی آموزشی نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
Preface Acknowledgments Contents 1: Positron Emission Tomography (PET) in Dementias Case 1.1 Probable Normal Brain FDG PET Study Clinical Information FDG PET Findings (Fig. 1.1) Discussion and Follow-Up Case Summary Case 1.2 Probable Normal Aging Clinical Information FDG PET Findings (Fig. 1.2) Discussion and Follow-Up Case Summary Case 1.3 Probable Mild Cognitive Impairment (MCI) Clinical Information FDG PET Findings (Fig. 1.3) Discussion and Follow-Up Case Summary Case 1.4 Probable Early-Onset Alzheimer’s Disease (EOAD) Clinical Information FDG PET Findings (Fig. 1.4) Discussion Case Summary Case 1.5 Probable Late-Onset Alzheimer’s Disease (LOAD) Clinical Information FDG PET Findings (Fig. 1.5) Discussion and Follow-Up Case Summary Case 1.6 Probable Frontotemporal Dementia (FTD) Clinical Information FDG PET Findings (Fig. 1.6) Discussion Case Summary Case 1.7 Probable Behavioral Variant FTD (bvFTD) Clinical Information FDG PET Findings (Fig. 1.7) Discussion Case Summary Case 1.8 Probable Semantic Variant Primary Progressive Aphasia (svPPA) Clinical Information FDG PET Findings (Fig. 1.8) Discussion Case Summary Case 1.9 Probable Corticobasal Degeneration (CBD) Clinical Information FDG PET Findings (Fig. 1.9) Discussion and Follow-Up Case Summary Case 1.10 Probable Dementia with Lewy Bodies (DLB) Clinical Information FDG PET Findings (Fig. 1.10) Discussion Case Summary Case 1.11 Probable AD with Vascular Pathology Clinical Information FDG PET Findings (Fig. 1.11) Discussion Case Summary Case 1.12 Dementia Resulting from Traumatic Brain Injury (TBI) Clinical Information FDG PET Findings (Fig. 1.12) Discussion Case Summary Case 1.13 Probable Vascular Dementia (VD) Clinical Information FDG PET Findings (Fig. 1.13) Discussion and Follow-Up Case Summary Case 1.14 Possible Mixed Dementia (AD with DLB Pathology) Clinical Information FDG PET Findings (Fig. 1.14) Discussion and Follow-Up Case Summary Case 1.15 Possible Mixed Dementia (FTD with AD Pathology) Clinical Information FDG PET Findings (Fig. 1.15) Discussion and Follow-Up Case Summary Case 1.16 Dementia Resulting from Major Depressive Disorder (MDD) Clinical Information FDG PET Findings (Fig. 1.16) Discussion and Follow-Up Case Summary Case 1.17 Aphasia Resulting from Brain Arteriovenous Malformation (AVM) Clinical Information FDG PET Findings (Fig. 1.17) Discussion and Follow-Up Case Summary Case 1.18 Dementia and Aphasia Resulting from Primary CNS Lymphoma (PCNSL) Clinical Information FDG PET Findings (Fig. 1.18) Discussion and Follow-Up Case Summary Case 1.19 Dementia of Unknown Type Clinical Information FDG PET Findings (Fig. 1.19) Discussion and Follow-Up Case Summary Case 1.20 Negative Amyloid Brain PET Scan Clinical Information F-18 Vizamyl PET/CT Imaging Findings (Fig. 1.20) Discussion and Follow-Up Case Summary Case 1.21 Positive Amyloid Brain PET Scan Clinical Information F-18 Vizamyl PET Imaging Findings (Fig. 1.21) Discussion and Follow-Up Case Summary References 2: Single Photon Emission Computed Tomography (SPECT) in Dementias Case 2.1 Probable Normal Aging Clinical Information SPECT Imaging Findings (Fig. 2.1) Discussion and Follow-Up Case Summary Case 2.2 Possible MCI Clinical Information SPECT Findings Discussions Case Summary Case 2.3 Possible Late-Onset Alzheimer’s Disease (LOAD) Clinical Information SPECT Imaging Findings (Fig. 2.3) Discussion and Follow-Up Case Summary Case 2.4 Probable Early-Onset Alzheimer’s Disease (EOAD) Clinical Information SPECT Imaging Findings (Fig. 2.4) Discussion Case Summary Case 2.5 Probable Frontotemporal Dementia (FTD) Clinical Information SPECT Imaging Findings Discussion and Follow-Up Case Summary Case 2.6 Probable Behavioral Variant Frontotemporal Dementia (bvFTD) Clinical Information SPECT Imaging Findings Discussion and Follow-Up Case Summary Case 2.7 Probable Dementia with Lewy Bodies (DLB) Clinical Information SPECT Imaging Findings Discussion and Follow-Up Case Summary Case 2.8 Probable Primary Progressive Aphasia (PPA) with AD Pathology Clinical Information SPECT Imaging Findings Discussion and Follow-Up Case Summary Case 2.9 Possible Vascular Dementia (VD) with bvFTD Pathology Clinical Information SPECT Imaging Findings (Fig. 2.9) Discussion and Follow-Up Case Summary Case 2.10 Probable Posterior Cortical Atrophy (PCA) Clinical Information SPECT Imaging Findings Discussion and Follow-Up Case Summary References 3: F-18 Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in Epilepsies Case 3.1 Negative FDG PET Clinical Information FDG PET Imaging Findings (Fig. 3.1) Discussion and Follow-Up Case Summary Case 3.2 Surgically Proven Left Mesial Temporal Lobe Epilepsy (MTLE) Clinical Information FDG PET Imaging Findings (Fig. 3.2) Discussion and Follow-Up Case Summary Case 3.3 Probable Right Lateral Temporal Lobe Epilepsy (LTLE) Clinical Information FDG PET Imaging Findings (Fig. 3.3) Discussion and Follow-Up Case Summary Case 3.4 Right Hemispheric Epilepsy Clinical Information FDG PET Imaging Findings (Fig. 3.4) Discussion and Follow-Up Case Summary Case 3.5 Probable Multifocal Epilepsy Clinical Information FDG PET Imaging Findings (Fig. 3.5) Discussion Case Summary Case 3.6 Ictal FDG PET Clinical Information FDG PET Imaging Findings (Fig. 3.6) Discussion and Follow-Up Case Summary Case 3.7 Surgically Proven Right Insular Lobe Epilepsy Clinical Information FDG PET Imaging Findings (Fig. 3.7) Discussion and Follow-Up Case Summary Case 3.8 Probable Right Frontal Lobe Epilepsy Clinical Information FDG PET Imaging Findings (Fig. 3.8) Discussion and Follow-Up Case Summary Case 3.9 Seizures Due to Left Temporal Astrocytoma Clinical Information FDG PET Imaging Findings Discussion and Follow-Up Case Summary Case 3.10 Seizures Resulting from Cerebral Cavernous Malformations (CCMs) Clinical Information FDG PET Imaging Findings (Fig. 3.10) Discussion and Follow-Up Case Summary Case 3.11 Seizures Due to Tuberous Sclerosis (TS) Clinical Information FDG PET Imaging Findings (Fig. 3.11) Discussion and Follow-Up Case Summary Case 3.12 Seizures Due to Intrauterine Stroke Clinical Information FDG PET Imaging Findings (Fig. 3.12) Discussion and Follow-Up Case Summary Case 3.13 Recurrent Seizures After Hemispherectomy Clinical Information FDG PET Imaging Findings (Fig. 3.13) Discussion and Follow-Up Case Summary References 4: Single Photon Emission Computed Tomography (SPECT) in Epilepsies Case 4.1 Probable Right Lateral Temporal Lobe Epilepsy (LTLE) Clinical Information SPECT and SISCOM Findings Discussion and Follow-Up Case Summary Case 4.2 Probable Left Occipitoparietal Epilepsy Clinical Information SPECT Findings (Fig. 4.2) Discussion and Follow-Up Case Summary Case 4.3 Probable Left Temporal Lobe Epilepsy (TLE) Clinical Information SPECT Findings (Fig. 4.3) Discussion and Follow-Up Case Summary Case 4.4 Surgically Proven Right Parietal Lobe Epilepsy (PLE) Due to Focal Cortical Dysplasia (FCD) Clinical Information SPECT and SISCOM Findings Discussion and Follow-Up Case Summary Case 4.5 Surgically Proven Left Lateral Temporal Lobe Epilepsy (LTLE) Clinical Information SPECT and SISCOM Findings Discussion and Follow-Up Summary Case 4.6 Probable Left Insular Epilepsy Clinical Information SPECT and SISCOM Findings Discussion and Follow-Up Case Summary Case 4.7 Probable Left Frontal Lobe Epilepsy (FLE) Clinical Information SPECT and SISCOM Findings Discussion and Follow-Up Case Summary Case 4.8 Multifocal Epilepsy Secondary to Tuberous Sclerosis (TS) Clinical Information SPECT and SISCOM Findings Discussions and Follow-Up Case Summary References 5: FDG PET Imaging of Brain Tumors Case 5.1 Primary Glioblastoma Multiforme (GBM) Clinical Information FDG PET CT Findings (Fig. 5.1) Discussion and Follow-Up Case Summary Case 5.2 Recurrent Glioblastoma Multiforme (GBM) Clinical Information FDG PET CT Findings (Fig. 5.2) Discussions and Follow-Up Case Summary Case 5.3 Primary CNS Lymphoma (PCNSL) Clinical Information FDG PET CT Findings (Fig. 5.3) Discussions and Follow-Up Case Summary Case 5.4 Secondary CNS Lymphoma (SCNSL) Clinical Information FDG PET CT Findings (Fig. 5.4) Discussion and Follow-Up Case Summary Case 5.5 Left Temporal Ganglioglioma Clinical Information FDG PET Findings (Fig. 5.5) Discussions and Follow-Up Case Summary Case 5.6 Leptomeningeal Melanoma Clinical Information FDG PET CT Findings (Fig. 5.6) Discussion and Follow-Up Case Summary Case 5.7 Multifocal Brain Metastases of Lung Origin Clinical Information Imaging Findings (Fig. 5.7) Discussion and Follow-Up Case Summary Case 5.8 Recurrent Brain Metastasis of Breast Origin Clinical Information FDG PET CT Findings (Fig. 5.8) Discussion and Follow-Up Case Summary References 6: Dopamine Transporter Scan (DaTscan) Case 6.1 Probable Normal DaTscan Consistent with Essential Tremor (ET) Clitnical Information DaTscan Findings Discussion and Follow-Up Case Summary Case 6.2 Abnormal DaTscan Likely due to PD and Coexisting AVM Clinical Information DaTscan Findings (Fig. 6.2) Discussion and Follow-Up Case Summary Case 6.3 Abnormal DaTscan due to Left-sided Stroke Clinical Information DaTscan Findings (Fig. 6.3) Discussion and Follow-Up Case Summary Case 6.4 Abnormal DaTscan with Right Striatum Being More Affected Than the Left Clinical Information DaTscan Findings (Fig. 6.4) Discussion and Follow-Up Case Summary Case 6.5 Probable Normal DaTscan Consistent with Neuroleptic-Induced Parkinsonism Clinical Information DaTscan Findings (Fig. 6.5) Discussion Case Summary Case 6.6 Abnormal DaTscan with Left Striatum Being More Affected Than the Right Clinical Information DaTscan Findings (Fig. 6.6) Discussion and Follow-Up Case Summary Case 6.7 Probable Abnormal DaTscan Suspicious for Early-Stage PD Clinical Information DaTscan Findings (Fig. 6.7) Discussion and Follow-Up Case Summary Case 6.8 Abnormal DaTscan due to CVA and Likely Early Stage of PD Clinical Information DaTscan Findings (Fig. 6.8) Discussion and Follow-Up Case Summary Case 6.9 Abnormal DaTscan Likely due to Corticobasal Degeneration (CBD) Clinical Information DaTscan Findings Discussion and Follow-Up Case Summary Case 6.10 Abnormal DaTscan Consistent with Advanced PD Clinical Information DaTscan Findings (Fig. 6.10) Discussion and Follow-Up Case Summary Case 6.11 Abnormal DaTscan due to Progressive Supranuclear Palsy (PSP) Clinical Information Imaging Findings Discussion and Follow-Up Case Summary Case 6.12 Abnormal DaTscan due to Multiple System Atrophy (MSA) Clinical Information Imaging Findings Discussion and Follow-Up Case Summary References 7: Cerebrospinal Fluid (CSF) Scintigraphy CSF Imaging in Normal Pressure Hydrocephalus (NPH) Case 7.1 Normal CSF Scintigraphy Clinical Information Imaging Findings (Fig. 7.1) Discussion and Follow-Up Case Summary Case 7.2 Slow CSF Flow and Transient Ventricular Reflux Likely Secondary to Brain Atrophy Clinical Information Imaging Findings (Fig. 7.2) Discussion and Follow-Up Case Summary Case 7.3 Abnormal CSF Scintigraphy Likely due to Hydrocephalus Ex Vacuo Clinical Information Imaging Findings (Fig. 7.3) Discussion and Follow-Up Case Summary Case 7.4 Abnormal CSF Scintigraphy Consistent with NPH Clinical Information Imaging Findings (Fig. 7.4) Discussion and Follow-Up Case Summary Case 7.5 NPH with a Favorable and Sustained Response to VP Shunting Clinical Information Imaging Findings (Fig. 7.5) Discussion and Follow-Up Case Summary CSF Leak Imaging Case 7.6 Normal Study Without Scintigraphic Evidence of CSF Leak Clinical Information Imaging Findings (Fig. 7.6) Discussion and Follow-Up Case Summary Case 7.7 Normal Study Including SPECT CT of the Head/Neck Without Evidence of CSF Leak Clinical Information Imaging Findings (Fig. 7.7) Discussion and Follow-Up Case Summary Case 7.8 CSF Leaks from T6 to L3 Clinical Information Imaging Findings (Fig. 7.8) Discussion and Follow-Up Case Summary Case 7.9 CSF Leak into Right Posterior Nasal Cavity Clinical Information Imaging Findings (Fig. 7.9) Discussion and Follow-Up Case Summary Case 7.10 Positive CSF Leak Imaging and Negative Follow-Up After Multiple Blood Patches Clinical Information Imaging Findings (Fig. 7.10) Discussion and Follow-Up Case Summary CSF Imaging in the Evaluation of Shunt Patency Case 7.11 Patent Lumboperitoneal (LP) Shunt Clinical Information Imaging Findings (Fig. 7.11) Discussion and Follow-Up Case Summary Case 7.12 Essentially Normal Ommaya Shunt Study Clinical Information Imaging Findings (Fig. 7.12) Discussion Case Summary Case 7.13 Patent Ommaya Shunt with Uneven CSF Flow/Distribution Clinical Information Imaging Findings (Fig. 7.13) Discussion and Follow-Up Case Summary Case 7.14 Patent Ventriculoperitoneal (VP) Shunt Clinical Information Imaging Findings (Fig. 7.14) Discussion Case Summary Case 7.15 Obstruction of the Proximal and Distal VP Shunt Catheters Clinical Information Imaging Findings (Fig. 7.15) Discussion and Follow-Up Case Summary Case 7.16 Obstruction of the Distal VP Shunt Catheter Clinical Information Imaging Findings (Fig. 7.16) Discussion and Follow-Up Case Summary References 8: Miscellaneous Clinical Nuclear Medicine Neuroimaging Studies Brain Death Scintigraphy Case 8.1 Positive Study Consistent with Brain Death Clinical Information Imaging Findings (Fig. 8.1) Discussion and Follow-Up Case Summary Case 8.2 Positive Brain Death Scintigraphy with a “Hot Nose Sign” Imaging Findings (Fig. 8.2) Discussion and Follow-Up Case Summary Brain Perfusion SPECT of Chronic Lyme Encephalopathy Case 8.3 Negative Study without Scintigraphic Evidence of Lyme Encephalopathy Imaging Findings (Fig. 8.3) Discussion and Follow-Up Case Summary Case 8.4 Abnormal Brain Perfusion Study Suspicious for Lyme Encephalopathy Imaging Findings (Fig. 8.4) Discussion and Follow-Up Case Summary Case 8.5 Positive Study for Chronic Lyme Encephalopathy with Improvement on Follow-Up Imaging Imaging Findings Discussion and Follow-Up Case Summary Case 8.6 Positive Study Consistent with Lyme Encephalopathy Without Interval Improvement on Follow-Up Imaging Clinical Information Imaging Findings Discussion and Follow-Up Case Summary Others Case 8.7 Brain Perfusion SPECT Study as Part of the Wada Test Imaging Findings (Fig. 8.7) Discussion and Follow-Up Case Summary Case 8.8 Intracerebral Steal Phenomenon (ISP) on Brain Perfusion SPECT with Diamox Challenge Imaging Findings Discussion and Follow-Up Case Summary Case 8.9 Brain FDG PET of Possible Mycoplasma Encephalitis Clinical Information Imaging Findings (Fig. 8.9) Discussion and Follow-Up Case Summary References Appendix I: Self-Assessment Quiz Quiz #1 Quiz #2 Quiz #3 Quiz #4 Quiz #5 Quiz #6 Quiz #7 Quiz #8 Quiz #9 Quiz #10 Quiz #11 Quiz #12 Quiz #13 Quiz #14 Quiz #15 Quiz #16 Quiz #17 Quiz #18 Quiz #19 Quiz #20 Quiz #21 Quiz #22 Quiz #23 Quiz #24 Quiz #25 Quiz #26 Quiz #27 Quiz #28 Quiz #29 Quiz #30 Correct Answers and Critiques Appendix II: Imaging Protocols FDG PET CT Brain Imaging Principle Indications in Our Clinic Radiopharmaceutical and Dosage Patient Preparation Procedure Amyoid PET Imaging of the Brain Principle Appropriate Clinical Indications Radiopharmaceutical and Dosage Patient Prep Procedure Brain Perfusion SPECT Principle Indications in Our Clinic Radiopharmaceutical and Dosage Patient Prep Procedure Equipment and Setup Brain Dopamine Transporter Scan (DaTscan) Principle Indications Radiopharmaceutical and Dosage Patient Prep Procedure Equipment Setup and Image Acquisition Cisternogram (CSF Scintigraphy) Purpose Indications Radiopharmaceutical and Dosage Patient Preparation/Scheduling Procedure CSF Leak Scintigraphy With or Without Pledgets Purpose Indications Radiopharmaceutical and Dosage Patient Preparation/Scheduling Procedure Radionuclide Imaging Evaluation of CSF Shunt Patency Purposes Radiopharmaceutical and Dosage Equipment Patient Prep Procedure Image Acquisition Image Interpretation Index